These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10519360)

  • 1. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
    Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
    Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression.
    Feenstra M; Verdaasdonk M; van der Zwan AW; de Weger R; Slootweg P; Tilanus M
    Lab Invest; 2000 Mar; 80(3):405-14. PubMed ID: 10744076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
    Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
    J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
    Zhao X; Sun Q; Tian H; Cong B; Jiang X; Peng C
    Asian Pac J Cancer Prev; 2011; 12(10):2741-5. PubMed ID: 22320985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
    Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
    Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
    Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
    Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
    McEvoy CR; Seshadri R; Morley AA; Firgaira FA
    Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas.
    Feenstra M; Rozemuller E; Duran K; Stuy I; van den Tweel J; Slootweg P; de Weger R; Tilanus M
    Hum Immunol; 1999 Aug; 60(8):697-706. PubMed ID: 10439315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
    Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
    Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
    Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
    Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
    Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors.
    Maleno I; Aptsiauri N; Cabrera T; Gallego A; Paschen A; López-Nevot MA; Garrido F
    Immunogenetics; 2011 Feb; 63(2):65-71. PubMed ID: 21086121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss.
    Koene GJ; Arts-Hilkes YH; van Dijk AJ; van der Ven KJ; Slootweg PJ; de Weger RA; Tilanus MG
    Hum Immunol; 2004 Dec; 65(12):1455-62. PubMed ID: 15603873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution mapping of chromosome 6 deletions in cervical cancer.
    Mazurenko N; Attaleb M; Gritsko T; Semjonova L; Pavlova L; Sakharova O; Kisseljov F
    Oncol Rep; 1999; 6(4):859-63. PubMed ID: 10373671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a putative HLA-A*31012 processed (intronless) pseudogene in a laryngeal squamous cell carcinoma.
    Feenstra M; Bakema J; Verdaasdonk M; Rozemuller E; van den Tweel J; Slootweg P; de Weger R; Tilanus M
    Genes Chromosomes Cancer; 2000 Jan; 27(1):26-34. PubMed ID: 10564583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
    del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
    Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
    Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
    Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.
    Hirata T; Yamamoto H; Taniguchi H; Horiuchi S; Oki M; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Apr; 211(5):516-523. PubMed ID: 17318812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.